Acute myocardial infarction complicated by systemic hypoperfusion without hypotension: Report of the SHOCK trial registry

American Journal of Medicine

Volumn 108, Issue 5, 2000, Pages 374-380

  Menon, Venu ^a   Slater, James N ^a   White, Harvey D ^b   Sleeper, Lynn A ^c   Cocke, Thomas ^d   Hochman, Judith S ^a  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b GREEN LANE HOSPITAL   (New Zealand)

^c NEW ENGLAND RESEARCH INSTITUTES   (United States)

^d MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; DOPAMINE; FIBRINOLYTIC AGENT; HYPERTENSIVE FACTOR; NORADRENALIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOGENIC SHOCK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART OUTPUT; HEMODYNAMICS; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERFUSION; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

AGED; CLINICAL TRIALS; FEMALE; HEMODYNAMIC PROCESSES; HOSPITAL MORTALITY; HUMANS; HYPOTENSION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; REGISTRIES; SHOCK, CARDIOGENIC;

EID: 0034176718     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(00)00310-7     Document Type: Article

References (23)

1. Holmes D.R. Jr, Bates E.R., Kleiman N.S., et al. Contemporary reperfusion therapy for cardiogenic shock the GUSTO-I trial experience . J Am Coll Cardiol. 26:1995;668-674.
2. Harnarayan C., Bennett M.A., Pentecost B.L., Brewer D.B. Quantitative study of infarcted myocardium in cardiogenic shock. Br Heart J. 32:1970;728-732.
3. Page D.L., Caulfield J.B., Kastor J.A., et al. Myocardial changes associated with cardiogenic shock. NEJM. 285:1971;133-137.
4. Alonso D.R., Scheidt S., Post M., Killip T. Pathophysiology of cardiogenic shock quantification of myocardial necrosis, clinical, pathologic and electrocardiographic correlations . Circulation. 48:1973;588-596.
5. Califf R.M., Bengtson J.R. Cardiogenic shock. NEJM. 330:1994;1724-1731.
6. Hochman J.S., Boland J., Sleeper L.A., et al. Current spectrum of cardiogenic shock and effect of early revascularization on mortality results of an international registry . Circulation. 9:1995;873-881.
7. Hochman J.S., Sleeper L.A., Godfrey E., et al. Should we emergently revascularize occluded coronaries for cardiogenic shock? An international randomized trial of emergency PTCA/CABG trial design . Am Heart J. 137:1999;313-321.
8. Lee K.L., Woodlief L.H., Topol E.J., et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Circulation. 91:1995;1659-1668.
9. Statistical Analysis System. Cary, NC: SAS Institute, Inc.
10. ACC/AHA guidelines for the management of patients with acute myocardial infarction. J Am Coll Cardiol. 1996;28:1328-1428.
11. Hasdai D., Holmes D.R. Jr, Califf R.M., et al. Cardiogenic shock complicating acute myocardial infarction predictors of death . Am Heart J. 138:1999;21-31.
12. Stamm R.B., Gibson R.S., Bishop H.L., et al. Echocardiographic detection of infarction correlation with the extent of angiographic disease . Circulation. 67:1983;233-244.
13. Gibson R.S., Bishop H.L., Stamm R.B., et al. Value of early two dimensional echocardiography in patients with myocardial infarction. Am J Cardiol. 49:1982;1110-1119.
14. Parisi A.F., Moynihan P.F., Folland E.D., et al. Echocardiography in acute and remote myocardial infarction. Am J Cardiol. 46:1980;1205-1214.
15. Leimbach W.N. Jr, Wallin B.G., Victor R.G., et al. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation. 73:1986;913-919.
16. Thomas J.A., Marks B.H. Plasma norepinephrine in congestive heart failure. Am J Cardiol. 41:1978;233-243.
17. Levine T.B., Francis G.S., Goldsmith S.R., et al. Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. Am J Cardiol. 49:1982;1659-1666.
18. Goldsmith S.R., Francis G.S., Cowley A.W., et al. Increased plasma arginine vasopressin levels in patients with congestive heart failure. J Am Coll Cardiol. 1:1983;1385-1390.
19. Cotter G., Kaluski E., Zaidenstein R., et al. L NMMA is effective in the treatment of cardiogenic shock. Circulation. 100:(suppl):1999;I1945.
20. Hochman J.S., Gersh B.J. Acute myocardial infarction complications . Topol E.J. Textbook of Cardiovascular Medicine. 1998;437-480 Lippincott-Raven, Philadelphia.
21. Menon V., Hochman J.S., White H.D., et al. Pre shock prognostic implications of systemic hypoperfusion without hypotension. Report of the SHOCK Trial Registry . Circulation. 98:(suppl):1998;I630.
22. Hochman J.S., Sleeper L.A., Webb J.G., et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. NEJM. 341:1999;625-634.
23. Ryan T.J., Antman E.M., Brooks N.H., et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the ACC/AHA Task Force on Practice Guidelines. J Am Coll Cardiol. 34:1999;890-911.